American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease
published online 17 September 2008.
At the end of this activity, the successful learner should:
1.Demonstrate an understanding of the natural history and manifestations of reflux disease
2.Evaluate the role of diagnostic testing such as endoscopy, esophageal manometry, ambulatory pH monitoring, and impedance-pH monitoring in the management of patients with gastroesophageal reflux disease
3.Evaluate the options for treatment of patients with complicated and uncomplicated reflux disease.
aDepartment of Medicine, Gastroenterology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois
bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
cDepartment of Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, Tennessee
Address requests for reprints to: Chair, Clinical Practice and Economics Committee, AGA Institute National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920
Supported by grant R01 DC00646 from the Public Health Service.
Peter J. Kahrilas is a consultant for AstraZeneca and TAP Pharmaceutical Products, Inc. Nicholas J. Shaheen is on the speaker's bureau for AstraZeneca and is a consultant for AstraZeneca and TAP Pharmaceutical Products, Inc and receives support (grant/research) from AstraZeneca, TAP Pharmaceutical Products, Inc, Proctor&Gamble, CCS Medical and Barrx Medical. Michael F. Vaezi is on the speaker's bureau of AstraZeneca, a consultant for AstraZeneca, Santarus, and Restech, and receives support (grant/research) from TAP Pharmaceutical Products, Inc, AstraZeneca, and Restech.
PREVIEW
American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease